(Q73135923)
Statements
Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group (English)
S C Apfel
S Schwartz
B T Adornato
R Freeman
V Biton
M Rendell
A Vinik
M Giuliani
J C Stevens
R Barbano